Pricing
  1. US-listed companies
  2. BIOLASE, INC
  3. Financials
  4. Working capital

BIOLASE, INC【BIOLQ】

Market cap
$36.6
P/E ratio
SummaryFinancials
Period EndWorking capital (Million USD)YoY (%)
Dec 31, 202311-31.64%
Dec 31, 202216+15.04%
Dec 31, 202114+19.50%
Dec 31, 202012-19.82%
Dec 31, 201914-17.14%
Dec 31, 201817+0.54%
Dec 31, 201717+22.08%
Dec 31, 201614-8.82%
Dec 31, 201516+18.24%
Dec 31, 201413-5.67%
Dec 31, 201314-8.01%
Dec 31, 201215+22.18%
Dec 31, 201112

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)